Urinary Incontinence and Sexual Function After the Introduction of NeuroSAFE in Radical Prostatectomy for Prostate Cancer

Eur Urol Focus. 2023 Sep;9(5):824-831. doi: 10.1016/j.euf.2023.03.021. Epub 2023 Apr 7.

Abstract

Background: Nerve-sparing (NS) radical prostatectomy (RP) results in better functional outcomes. Intraoperative neurovascular structure-adjacent frozen section examination (NeuroSAFE) significantly increases the frequency of NS surgery. The effect of NeuroSAFE on postoperative erectile function (EF) and continence is not yet clear.

Objective: To describe EF and continence outcomes for men undergoing RP with the NeuroSAFE technique.

Design, setting, and participants: Between September 2018 and February 2021, 1034 men underwent robot-assisted RP. Data for patient-reported outcomes were collected via validated questionnaires.

Intervention: NeuroSAFE technique for RP.

Outcome measurements and statistical analysis: Continence was assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) or Expanded Prostate Cancer Index Composite short form (EPIC-26) and defined as use of 0-1 pads/d. EF was evaluated using EPIC-26 or the International Index of Erectile Function short form (IIEF-5), with data converted according to the Vertosick method and categorized. Descriptive statistics were used to asses and describe tumor characteristics and continence and EF outcomes.

Results and limitations: Of the 1034 men who underwent RP after introduction of the NeuroSAFE technique, 63% and 60% completed a preoperative and at least one postoperative questionnaire on continence and EF, respectively. Of the men who underwent unilateral or bilateral NS surgery, use of 0-1 pads/d was reported by 93% after 1 yr and 96% after 2 yr; the corresponding rates for men who underwent non-NS surgery were 86% and 78%. Overall, use of 0-1 pads/d was reported by 92% of the men at 1 yr and by 94% at 2 yr after RP. Men in the NS group had a good or intermediate Vertosick score after RP more often than the non-NS group. Overall, 44% of the men had a good or intermediate Vertosick score at 1 and 2 yr after RP.

Conclusions: After introduction of the NeuroSAFE technique, the continence rate was 92% at 1 yr and 94% at 2 yr after RP. The NS group had a greater percentage of men with an intermediate or good Vertosick score and a higher continence rate after RP in comparison to the non-NS group.

Patient summary: Our study shows that after introduction of the NeuroSAFE technique during removal of the prostate, the continence rate among patients was 92% at 1 year and 94% at 2 years after surgery. Some 44% of the men had a good or intermediate score for erectile function 1 and 2 years after surgery.

Keywords: Patient reported outcome; Prostate cancer; Radical prostatectomy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Erectile Dysfunction* / epidemiology
  • Erectile Dysfunction* / etiology
  • Erectile Dysfunction* / surgery
  • Frozen Sections
  • Humans
  • Male
  • Prostate / pathology
  • Prostatectomy / adverse effects
  • Prostatectomy / methods
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms* / surgery
  • Urinary Incontinence* / diagnosis
  • Urinary Incontinence* / epidemiology
  • Urinary Incontinence* / etiology